2m 2m 2m 2m 2m 2m 2m
GSK Sp ADR (GSK)
NYSE
$52.61+$0.20 (+0.37%)
Price as of Aug 21, 2026 7:59 PM EDT- $105.0BMarket Cap
- 35.03%1-Year Change
- Drug Manufacturers - GeneralIndustry
GSK Sp ADR (GSK)
$52.61+$0.20 (+0.37%)
GSK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $52.41 | ||
Change | +$0.45 (+0.87%) | ||
Open | $51.35 | ||
High | $52.57 | ||
Low | $51.35 | ||
Previous Close | $51.96 | ||
Volume | 2,404,982 | ||
30-Day Average Volume | 4,044,303 | ||
1-Week Change | 5.84% | ||
1-Month Change | 4.14% | ||
1-Year Change | 35.03% | ||
3-Year Change | 70.64% | ||
5-Year Change | 22.65% | ||
Fundamentals | |||
Shares Outstanding | 2.0B | ||
Total Assets | $61.1B | ||
Market Cap | $105.0B | ||
Enterprise Value | $104.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 3.45% | ||
Trailing Annual Dividend Yield | 3.47% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | 4 : 5 | ||
Last Split Date | 07/19/2022 | ||
Earnings & Revenue
Annual Dividend Yield